AtriCure
ATRC
55.39
+1.28
+2.37%
AtriCure
US · ATRC
#2543 by market cap
Listed 1970
55.39
+1.28
+2.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
2
■ Upgrades■ Downgrades
- 0 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: Freedom Capital Markets moved from Buy to Hold on 2026-10-02.
Analyst consensus 8 analysts
Buy
Avg price target 66.00 +19.2%
Price target rangecurrent 55.39
Low57.00
Avg66.00
High70.00
Buy 75%
Hold 25%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-12 | Stifel | -- | Buy | 70.00 |
| 2026-11-04 | CCORF | -- | Buy | 67.00 |
| 2026-11-04 | Piper Sandler | -- | Buy | 70.00 |
| 2026-11-04 | Stifel | -- | Buy | 70.00 |
| 2026-11-04 | J.P. Morgan | -- | Hold | 62.00 |
| 2026-11-03 | BTIG | -- | Buy | 70.00 |
| 2026-10-21 | Citizens JMP | -- | Buy | 68.00 |
| 2026-10-12 | BTIG | -- | Buy | 63.00 |
| 2026-10-02 | Freedom Capital Markets | -- | Hold | 57.00 |
| 2026-09-17 | Stifel | -- | Buy | 65.00 |
| 2026-09-02 | Needham | -- | Buy | 64.00 |
| 2026-08-27 | Piper Sandler | -- | Buy | 60.00 |
| 2026-08-24 | BTIG | -- | Buy | 55.00 |
| 2026-08-11 | CCORF | -- | Buy | 55.00 |
| 2026-07-28 | UBS | -- | Buy | 50.00 |
| 2026-07-24 | Piper Sandler | -- | Buy | 50.00 |
| 2026-07-24 | BTIG | -- | Buy | 45.00 |
| 2026-07-24 | Freedom Capital Markets | -- | Buy | 43.00 |
| 2026-07-24 | Stifel | -- | Buy | 50.00 |
| 2026-07-24 | Needham | -- | Buy | 45.00 |
| 2026-07-24 | Oppenheimer | -- | Hold | -- |
| 2026-07-24 | J.P. Morgan | -- | Hold | 36.00 |
| 2026-07-23 | CCORF | -- | Buy | 55.00 |
| 2026-07-13 | Needham | -- | Buy | 45.00 |
| 2026-07-10 | BTIG | -- | Buy | 45.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-02 | Freedom Capital Markets | Buy → Hold | 57.00 |
| 2026-07-24 | J.P. Morgan | Buy → Hold | 36.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | After close | ±11.72% | +8.48% (in line) |
| 2026/Q2 | 2026-07-23 | After close | ±18.71% | +6.18% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±15.20% | -4.70% (in line) |
| 2025/Q4 | 2026-02-17 | After close | ±17.74% | -2.15% (in line) |
| 2025/Q3 | 2025-10-29 | After close | ±17.58% | -3.81% (in line) |
| 2025/Q2 | 2025-07-29 | After close | -- | +10.72% |
| 2025/Q1 | 2025-04-29 | After close | -- | -13.68% |
| 2024/Q4 | 2025-02-12 | After close | ±13.93% | -6.54% (in line) |
| 2024/Q3 | 2024-10-29 | -- | ±19.45% | +18.35% (in line) |
| 2024/Q2 | 2024-07-30 | -- | ±21.25% | -1.95% (in line) |
| 2024/Q1 | 2024-05-01 | After close | ±16.60% | -10.26% (in line) |
| 2023/Q4 | 2024-02-15 | After close | ±19.00% | -4.36% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
AtriCure discussion 0 comments